STOCK TITAN

IDEXX Laboratories Stock Price, News & Analysis

IDXX Nasdaq

Welcome to our dedicated page for IDEXX Laboratories news (Ticker: IDXX), a resource for investors and traders seeking the latest updates and insights on IDEXX Laboratories stock.

IDEXX Laboratories (IDXX) delivers essential diagnostic solutions and practice management tools for veterinary professionals worldwide. This dedicated news hub provides investors and industry stakeholders with timely updates on corporate developments shaping animal healthcare innovation.

Access official press releases and verified news covering financial results, product launches, regulatory milestones, and strategic partnerships. Our curated collection ensures transparent tracking of IDXX's advancements in in-clinic testing systems, reference laboratory services, and integrated practice software solutions.

Key updates include earnings announcements, diagnostic technology innovations, livestock health initiatives, and global expansion efforts. Bookmark this page for efficient monitoring of developments affecting veterinary diagnostics markets and IDXX's position as a leader in animal health solutions.

Rhea-AI Summary

IDEXX Laboratories (NASDAQ: IDXX) announced that Brian McKeon, EVP & CFO, and Michael Lane, EVP & GM of Reference Laboratories and IT, will participate in a fireside chat at the Stifel Jaws & Paws Conference on May 29, 2024, from 10:55 am to 11:25 am (EDT). A live audio webcast will be available on IDEXX's website, with an archived edition accessible later.

The company also announced its 2024 Investor Day on August 15, 2024, at its headquarters in Westbrook, Maine, from 8:00 am to 12:00 pm (EDT). The event will be webcast live, with advance registration required for in-person attendance by institutional investors and analysts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.6%
Tags
conferences
-
Rhea-AI Summary

IDEXX Laboratories, a global leader in pet healthcare innovation, announced first quarter results with revenue growth of 7% supported by CAG Diagnostics recurring revenue growth of 7%. The company achieved EPS of $2.81 and updated its 2024 revenue guidance to $3,895 million - $3,965 million, and EPS outlook to $10.82 - $11.20.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.53%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.02%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none

FAQ

What is the current stock price of IDEXX Laboratories (IDXX)?

The current stock price of IDEXX Laboratories (IDXX) is $542.71 as of July 2, 2025.

What is the market cap of IDEXX Laboratories (IDXX)?

The market cap of IDEXX Laboratories (IDXX) is approximately 42.7B.
IDEXX Laboratories

Nasdaq:IDXX

IDXX Rankings

IDXX Stock Data

42.66B
79.87M
0.96%
93.21%
3.37%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
WESTBROOK